Results 211 to 220 of about 18,513 (261)

Intraductal papillary mucinous neoplasms

Current Opinion in Gastroenterology, 2015
Our understanding of intraductal papillary mucinous neoplasm (IPMN) of the pancreas has remarkably grown within the last decade; nonetheless there is still an ongoing controversy if the majority of these potentially malignant neoplasms need to be resected or if observation in a subset is well tolerated.Novel cyst fluid biomarkers, like Gnas mutations ...
Carlos Fernandez-del Castillo, Klaus Sahora   +1 more
openaire   +3 more sources

Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center.

Gastroenterology, 2017
BACKGROUND & AIMS Little is known about the development of branch duct intraductal papillary mucinous neoplasms (BD-IPMNs). We evaluated long-term outcomes of a large cohort of patients with BD-IPMNs to determine risk of malignancy and define a subset of
I. Pergolini, K. Sahora, C. Ferrone, V. Morales-Oyarvide, B. Wolpin, L. Mucci, W. Brugge, M. Mino‐Kenudson, M. Patiňo, D. Sahani, A. Warshaw, K. Lillemoe, C. F. Fernandez-Del Castillo   +12 more
semanticscholar   +1 more source

Determining Malignant Potential of Intraductal Papillary Mucinous Neoplasm of the Pancreas: CT versus MRI by Using Revised 2017 International Consensus Guidelines.

Radiology, 2019
Background Several changes have been made to the revised 2017 international consensus guidelines for management of pancreatic intraductal papillary mucinous neoplasms (IPMNs). However, the diagnostic performance is yet to be verified. Purpose To evaluate
J. E. Lee, Seo-Youn Choi, J. Min, B. Yi, Min Hee Lee, Seung Soo Kim, Jeong Ah Hwang, J. H. Kim   +7 more
semanticscholar   +1 more source

New Model for Predicting Malignancy in Patients With Intraductal Papillary Mucinous Neoplasm.

Annals of Surgery, 2018
OBJECTIVE To create a simple, objective model to predict the presence of malignancy in patients with intraductal papillary mucinous neoplasm (IPMN), which can be easily applied in daily practice and, importantly, adopted for any lesion types ...
Y. Shimizu, S. Hijioka, S. Hirono, T. Kin, T. Ohtsuka, A. Kanno, Shinsuke Koshita, K. Hanada, M. Kitano, H. Inoue, T. Itoi, T. Ueki, K. Matsuo, A. Yanagisawa, H. Yamaue, M. Sugiyama, K. Okazaki   +16 more
semanticscholar   +1 more source

Intraductal papillary mucinous neoplasm of pancreas

Khirurgiya. Zhurnal im. N.I. Pirogova, 2019
Intraductal papillary mucinous neoplasm (IPMN) is the most common cystic pancreatic tumor. There are 3 ductal types of this tumor depending on localization. Several histological subtypes determine clinical course and prognosis. The problems of diagnosis, surgical treatment and follow-up are reviewed in several guidelines.
Kriger Ag, A. R. Kaldarov, V I Panteleev, Gorin Ds   +3 more
openaire   +2 more sources

Intraductal papillary mucinous neoplasms of the pancreas

European Journal of Surgical Oncology (EJSO), 2007
Intraductal papillary mucinous neoplasms (IPMNs) are neoplasms of the pancreatic duct epithelium characterized by intraductal papillary growth and thick mucin secretion. Quantities of mucin fill the main and/or branches of pancreatic ducts and cause ductal dilatation.
Stavros Gourgiotis, Marco Pericoli Ridolfini, Stylianos Germanos   +2 more
openaire   +2 more sources

Intraductal Papillary Mucinous Neoplasm

Journal of Insurance Medicine, 2016
Intraductal papillary mucinous neoplasms are cystic growths often noted incidentally in the pancreatic ducts. Left untreated, some may progress to invasive cancer.
openaire   +3 more sources

Intraductal papillary mucinous neoplasm

Current Treatment Options in Gastroenterology, 2002
Surgical resection is the treatment of choice for intraductal papillary mucinous tumor. In intraductal papillary mucinous neoplasm, the extent of resection is determined by the extent of the disease. If, by pre- and intraoperative assessment, the disease appears localized, limited resection (pancreaticoduodenectomy or distal pancreatectomy) should be ...
openaire   +3 more sources

Management of intraductal papillary mucinous neoplasms

Current Gastroenterology Reports, 2008
Intraductal papillary mucinous neoplasms (IPMNs) of the pancreas are being diagnosed with increasing frequency, probably due to the widespread use of cross-sectional imaging. The natural history of these tumors is still largely unknown. Several studies have shown topographical as well as biological differences between main duct and branch duct IPMNs ...
Stefano Crippa, Carlos Fernandez-del Castillo   +1 more
openaire   +3 more sources

Usefulness of septal thickness measurement on endoscopic ultrasound as a predictor of malignancy of branched‐duct and mixed‐type intraductal papillary mucinous neoplasm of the pancreas

Digestive Endoscopy, 2019
Septal thickness (ST) can predict a malignant branch‐duct (BD) and mixed‐type intraductal papillary mucinous neoplasm (IPMN) of the pancreas, but its cut‐off value has not been established. The aim of the present study was to determine the optimal ST cut‐
Hiromichi Iwaya, S. Hijioka, N. Mizuno, Takamichi Kuwahara, Nozomi Okuno, M. Tajika, Tsutomu Tanaka, M. Ishihara, Y. Hirayama, S. Onishi, Ayako Ito, Naosuke Kuraoka, Shinpei Matsumoto, Petcharee Polmanee, Y. Shimizu, Y. Yatabe, Y. Niwa, K. Tamada, A. Ido, K. Hara   +19 more
semanticscholar   +1 more source